EP3794345
OPTIMIZED SIGMA-1 AGONIST METHOD OF RESPONDER SELECTION AND TREATMENT
:
EP einkaleyfi: Þýðing ekki lögð inn:
20.5.2019:
26.2.2025:
19802944.9
:
19.5.2039
:
OPTIMIZED SIGMA-1 AGONIST METHOD OF RESPONDER SELECTION AND TREATMENT
20.5.2019
26.2.2025
:
Anavex Life Sciences Corp.:
51 West 52nd Street 7th Floor, New York, NY 10019, US
:
MISSLING, Christopher U.:
New York, New York 10019, US
:
AFSHAR, Mohammad Michel:
75016 Paris, FR
:
PARMENTIER, Frédéric:
94260 Fresnes, FR
:
201862673369 P:
18.5.2018:
US
:
US2019033161:
20.5.2019
:
G01N 33/49, C12Q 1/6883, C12Q 1/6876, C12Q 1/6886